Adrenal Cancer Diagnostics Global Market Report 2024

Description

Adrenal cancer diagnostics involve the identification and detection of cancer originating in the adrenal glands, situated above the kidneys. This process encompasses a series of medical assessments, tests, and procedures designed to establish the presence of adrenal cancer, playing a crucial role in effective treatment planning and management.

The primary diagnostic tests for adrenal cancer include magnetic resonance imaging (MRI), computed tomography (CT) scans, X-rays, positron emission tomography (PET) scans, and biopsies. Magnetic resonance imaging (MRI) is a medical imaging technique that utilizes strong magnetic fields and radio waves to generate detailed and high-resolution images of the body's internal structures. Treatment modalities encompass surgery, chemotherapy, radiotherapy, targeted cancer therapies, and others tailored for pheochromocytoma, adrenal cortical carcinoma, and various tumor types. These treatments are administered by diverse end-users such as hospitals, ambulatory surgical centers, cancer centers, and others.

The adrenal cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides adrenal cancer diagnostics market statistics, including adrenal cancer diagnostics industry global market size, regional shares, competitors with an adrenal cancer diagnostics market share, detailed adrenal cancer diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the adrenal cancer diagnostics industry. This adrenal cancer diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The adrenal cancer diagnostics market size has grown strongly in recent years. It will grow from $130.84 billion in 2023 to $140.35 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth observed in the historical period can be ascribed to an elevated incidence and awareness of the condition, advancements in genetic and molecular testing, improvements in biopsy techniques, enhanced endocrine testing, and the integration of artificial intelligence (AI).

The adrenal cancer diagnostics market size is expected to see strong growth in the next few years. It will grow to $180.09 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%. The anticipated growth in the forecast period can be attributed to the adoption of personalized medicine approaches, an increase in minimally invasive procedures, the integration of telemedicine and remote consultations, the development of liquid biopsy techniques, and the expansion of genetic counseling services. Key trends expected in the forecast period include regulatory support for diagnostic innovations, the adoption of digital pathology, advancements in imaging technologies, ongoing progress in liquid biopsy development, and the application of genomic profiling for precision medicine.

The anticipated rise in cigarette smoking is poised to drive the growth of the adrenal cancer diagnostics market. Cigarette smoking involves inhaling and exhaling fumes from burning tobacco containing nicotine, an addictive alkaloid with psychoactive effects. Adrenal cancer, including adenomas and adrenocortical carcinomas, has been linked to increased risks associated with cigarette smoking. The carcinogens in tobacco smoke can lead to DNA damage in adrenal cells, resulting in mutations that may cause cancer. Notably, Statistics Canada reported a 5.8% increase in cigarette production in July 2022 compared to June 2021, with the total number of cigarettes sold reaching 1.4 billion in June 2022. Thus, the growing prevalence of cigarette smoking is a key driver for the adrenal cancer diagnostics market.

Government initiatives supporting cancer are expected to propel the growth of the adrenal cancer diagnostics market. These initiatives involve significant actions taken by governments to address challenges, improve diagnostic services' quality and accessibility, and support research for effective adrenal cancer diagnostics. In April 2023, the Biden-Harris administration, as per the National Institutes of Health (NIH), established an initiative to reduce cancer-related deaths by 50% within 25 years while enhancing support for individuals enduring and surviving cancer. Government initiatives contribute significantly to driving the growth of the adrenal cancer diagnostics market.

A substantial obstacle to the adrenal cancer diagnostics market is the high cost of diagnostic imaging systems. The expense associated with these systems and procedures poses challenges in terms of access to timely and accurate diagnoses, potentially leading to delayed treatment and financial burdens for patients. According to the American College of Physicians, surplus imaging costs the healthcare system between $200-$250 billion annually. Therefore, the considerable cost linked to diagnostic imaging systems represents a significant constraint for the adrenal cancer diagnostics market.

Major companies in the adrenal cancer diagnostics market are enhancing profitability by developing innovative products incorporating advanced technologies such as the High-V MRI platform and DryCool technology. The High-V MRI platform integrates digitalization with a new field strength of 0.55T, ensuring exceptional diagnostic quality for routine and new clinical applications. Meanwhile, DryCool technology is a virtually helium-free scanner utilizing a closed-loop cooling system to cool the magnet. Siemens Healthcare GmbH introduced the Magnetom Free.Star1 MRI scanner in November 2021 for adrenal cancer diagnostics. This cost-effective and user-friendly scanner, based on Siemens Healthineers' High-V MRI platform and DryCool technology, is expected to facilitate earlier and more accurate diagnoses, improving patient outcomes across various medical conditions.

In May 2021, Exact Sciences Corp., a US-based molecular diagnostics company, acquired Thrive Earlier Detection Corp. for $2.15 billion. This strategic move by Exact Sciences aims to expand its presence in the early cancer detection market, strengthen its competitive position, and accelerate the development and commercialization of THX-251. Thrive Earlier Detection Corp., a US-based biotechnology company, specializes in products related to adrenal cancer diagnostics.

Major companies operating in the adrenal cancer diagnostics market report are Johnson And Johnson Pvt Ltd., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, GSK plc, AstraZeneca plc, Abbott Laboratories, Siemens Healthcare GmbH, Becton Dickinson and Company, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Agilent Technologies, Hologic Inc., PerkinElmer Inc., Illumina Inc., Roche Diagnostics, BioMerieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Exact Sciences Corp., Natera Inc., Invitae Corporation, Qiagen NV, Guardant Health Inc., Foundation Medicine Inc., NanoString Technologies Inc., TRS Technologies Inc., Morgan Advanced Materials, APC International Ltd., Annon Piezo Technology Co. Limited

North America was the largest region in the adrenal cancer diagnostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adrenal cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the adrenal cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The adrenal cancer diagnostics market consists of revenues earned by entities by providing genetic testing, histopathology, blood tests, and dexamethasone suppression tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The adrenal cancer diagnostics market also includes sales of ultrasound machines, reagents and test kits, microscopes, histology kits, and microtomes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Adrenal Cancer Diagnostics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on adrenal cancer diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for adrenal cancer diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The adrenal cancer diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Test: Magnetic Resonance Imaging (MRI); Computed Tomography (CT) Scan; X-ray; Positron Emission Tomography (PET) Scan; Biopsy
2) By Treatment: Surgery; Chemotherapy; Radiotherapy; Targeted Cancer Therapies; Other Treatments
3) By Tumor Type: Pheochromocytoma; Adrenal Cortical Carcinoma; Other Types
4) By End-User: Hospitals; Ambulatory Surgical Centers; Cancer Centers; Other End-Users
Companies Mentioned: Johnson And Johnson Pvt Ltd.; F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific; GSK plc; AstraZeneca plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r13455

1. Executive Summary

2. Adrenal Cancer Diagnostics Market Characteristics

3. Adrenal Cancer Diagnostics Market Trends And Strategies

4. Adrenal Cancer Diagnostics Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Adrenal Cancer Diagnostics Market Size and Growth

5.1. Global Adrenal Cancer Diagnostics Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Adrenal Cancer Diagnostics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Adrenal Cancer Diagnostics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Adrenal Cancer Diagnostics Market Segmentation

6.1. Global Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Magnetic Resonance Imaging (MRI)
Computed Tomography (CT) Scan
X-ray
Positron Emission Tomography (PET) Scan
Biopsy
6.2. Global Adrenal Cancer Diagnostics Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Surgery
Chemotherapy
Radiotherapy
Targeted Cancer Therapies
Other Treatments
6.3. Global Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Pheochromocytoma
Adrenal Cortical Carcinoma
Other Types
6.4. Global Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Ambulatory Surgical Centers
Cancer Centers
Other End-Users

7. Adrenal Cancer Diagnostics Market Regional And Country Analysis

7.1. Global Adrenal Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Adrenal Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Adrenal Cancer Diagnostics Market

8.1. Asia-Pacific Adrenal Cancer Diagnostics Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Adrenal Cancer Diagnostics Market

9.1. China Adrenal Cancer Diagnostics Market Overview
9.2. China Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Adrenal Cancer Diagnostics Market

10.1. India Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Adrenal Cancer Diagnostics Market

11.1. Japan Adrenal Cancer Diagnostics Market Overview
11.2. Japan Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Adrenal Cancer Diagnostics Market

12.1. Australia Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Adrenal Cancer Diagnostics Market

13.1. Indonesia Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Adrenal Cancer Diagnostics Market

14.1. South Korea Adrenal Cancer Diagnostics Market Overview
14.2. South Korea Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Adrenal Cancer Diagnostics Market

15.1. Western Europe Adrenal Cancer Diagnostics Market Overview
15.2. Western Europe Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Adrenal Cancer Diagnostics Market

16.1. UK Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Adrenal Cancer Diagnostics Market

17.1. Germany Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Adrenal Cancer Diagnostics Market

18.5. France Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.6. France Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.7. France Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Adrenal Cancer Diagnostics Market

19.9. Italy Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.10. Italy Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.11. Italy Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Adrenal Cancer Diagnostics Market

20.13. Spain Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.14. Spain Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.15. Spain Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Adrenal Cancer Diagnostics Market

21.1. Eastern Europe Adrenal Cancer Diagnostics Market Overview
21.2. Eastern Europe Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Adrenal Cancer Diagnostics Market

22.1. Russia Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Adrenal Cancer Diagnostics Market

23.1. North America Adrenal Cancer Diagnostics Market Overview
23.2. North America Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Adrenal Cancer Diagnostics Market

24.1. USA Adrenal Cancer Diagnostics Market Overview
24.2. USA Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Adrenal Cancer Diagnostics Market

25.1. Canada Adrenal Cancer Diagnostics Market Overview
25.2. Canada Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Adrenal Cancer Diagnostics Market

26.1. South America Adrenal Cancer Diagnostics Market Overview
26.2. South America Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Adrenal Cancer Diagnostics Market

27.1. Brazil Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Adrenal Cancer Diagnostics Market

28.1. Middle East Adrenal Cancer Diagnostics Market Overview
28.2. Middle East Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Adrenal Cancer Diagnostics Market

29.1. Africa Adrenal Cancer Diagnostics Market Overview
29.2. Africa Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Adrenal Cancer Diagnostics Market Competitive Landscape And Company Profiles

30.1. Adrenal Cancer Diagnostics Market Competitive Landscape
30.2. Adrenal Cancer Diagnostics Market Company Profiles
- 30.2.1. Johnson And Johnson Pvt Ltd.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. F. Hoffmann-La Roche Ltd.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Thermo Fisher Scientific
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. GSK plc
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. AstraZeneca plc
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Adrenal Cancer Diagnostics Market Other Major And Innovative Companies

31.1. Abbott Laboratories
31.2. Siemens Healthcare GmbH
31.3. Becton Dickinson and Company
31.4. Koninklijke Philips N.V.
31.5. GE HealthCare Technologies Inc.
31.6. Agilent Technologies
31.7. Hologic Inc.
31.8. PerkinElmer Inc.
31.9. Illumina Inc.
31.10. Roche Diagnostics
31.11. BioMerieux SA
31.12. Sysmex Corporation
31.13. Bio-Rad Laboratories Inc.
31.14. Bruker Corporation
31.15. Exact Sciences Corp.

32. Global Adrenal Cancer Diagnostics Market Competitive Benchmarking

33. Global Adrenal Cancer Diagnostics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Adrenal Cancer Diagnostics Market

35. Adrenal Cancer Diagnostics Market Future Outlook and Potential Analysis

35.1 Adrenal Cancer Diagnostics Market In 2028 - Countries Offering Most New Opportunities
35.2 Adrenal Cancer Diagnostics Market In 2028 - Segments Offering Most New Opportunities
35.3 Adrenal Cancer Diagnostics Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer